Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease

NCT07639034 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gordon Schanzlin New Vision